CTOs on the Move

JenaValve

www.jenavalve.com

 
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.jenavalve.com
  • 1000 N. West Street Suite 1200
    Wilmington, DE USA 19801
  • Phone: 302.295.4897

Executives

Name Title Contact Details

Similar Companies

Vertiflex Inc

Vertiflex is committed to delivering clinically proven treatments for lumbar stenosis that are minimally invasive in order to help people take back their lives.

Molnlycke

A world-leading medical solutions company We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.

Volu-Sol

Volu-Sol is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envirco Corp

Envirco Corp is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

F2 Creations

F2 Creations is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.